Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Statements of Operations and Comprehensive Loss

v3.25.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Research and development $ 19,057 $ 13,110
General and administrative 7,624 8,157
Total operating expenses 26,681 21,267
Operating loss (26,681) (21,267)
Other income, net 2,267 1,929
Total other income, net 2,267 1,929
Loss before income tax expense (24,414) (19,338)
Income tax expense (30) (43)
Net loss (24,444) (19,381)
Other comprehensive income    
Unrealized gain on marketable securities 17 80
Comprehensive loss $ (24,427) $ (19,301)
Basic and diluted net loss per share (in dollars per share) $ (0.6) $ (0.6)
Weighted average shares outstanding – basic and diluted (in shares) 40,404,681 32,566,723